Race and Beta‐Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self‐Reported Race and Proportion of African Genetic Ancestry

Author:

Luzum Jasmine A.12,Peterson Edward3,Li Jia3,She Ruicong3,Gui Hongsheng2,Liu Bin3,Spertus John A.4,Pinto Yigal M.5,Williams L. Keoki26,Sabbah Hani N.7,Lanfear David E.27

Affiliation:

1. Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI

2. Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI

3. Department of Public Health Sciences, Henry Ford Health System, Detroit, MI

4. Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO

5. Department of Cardiology, University of Amsterdam, Amsterdam, The Netherlands

6. Department of Internal Medicine, Henry Ford Health System, Detroit, MI

7. Heart and Vascular Institute, Henry Ford Health System, Detroit, MI

Abstract

Background It remains unclear whether beta‐blockade is similarly effective in black patients with heart failure and reduced ejection fraction as in white patients, but self‐reported race is a complex social construct with both biological and environmental components. The objective of this study was to compare the reduction in mortality associated with beta‐blocker exposure in heart failure and reduced ejection fraction patients by both self‐reported race and by proportion African genetic ancestry. Methods and Results Insured patients with heart failure and reduced ejection fraction (n=1122) were included in a prospective registry at Henry Ford Health System. This included 575 self‐reported blacks (129 deaths, 22%) and 547 self‐reported whites (126 deaths, 23%) followed for a median 3.0 years. Beta‐blocker exposure ( BB exp) was calculated from pharmacy claims, and the proportion of African genetic ancestry was determined from genome‐wide array data. Time‐dependent Cox proportional hazards regression was used to separately test the association of BB exp with all‐cause mortality by self‐reported race or by proportion of African genetic ancestry. Both sets of models were evaluated unadjusted and then adjusted for baseline risk factors and beta‐blocker propensity score. BB exp effect estimates were protective and of similar magnitude both by self‐reported race and by African genetic ancestry (adjusted hazard ratio=0.56 in blacks and adjusted hazard ratio=0.48 in whites). The tests for interactions with BB exp for both self‐reported race and for African genetic ancestry were not statistically significant in any model ( P >0.1 for all). Conclusions Among black and white patients with heart failure and reduced ejection fraction, reduction in all‐cause mortality associated with BB exp was similar, regardless of self‐reported race or proportion African genetic ancestry.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3